Jean Jacques Bienaime

Director

Director at Keros Therapeutics, Inc., filing insider transactions between 2026-07-15 and 2026-08-17. Also reports transactions at 1 other company.

Total Purchases

$514K

4 transactions

Total Sales

—

0 transactions

Companies Traded

4 total filings

Active Since

2026-07-15

Last: 2026-08-17

Companies

Keros Therapeutics, Inc.

Ascendis Pharma A/S

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-17	KROS	Purchase	1,000	$10.27	$10K	19.6K	SEC ↗
2026-08-14	ASND	Purchase	1,100	$245.85	$270K	2,000	SEC ↗
2026-08-14	ASND	Purchase	900	$246.91	$222K